The influence of polyvinylpyrrolidone on furosemide complexation with randomly-methylated-β-cyclodextrin

Revista de Chimie

Volumn 57, Issue 7, 2006, Pages 726-730

  Şoica, Codruţa ^a   Gyéresi, Árpad ^b   Aigner, Zoltan ^c   Kata, Mihaly ^c   Dehelean, Cristina ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Bioavailability; Furosemide; PVP; RAMEB; Solubility

Indexed keywords

EID: 33847147120     PISSN: 00347752     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. DOLLERY C.T., Therapeutic Drugs, Churchill Livingstone, New York, 1999, p.125
2. KREAZ R.M., ABU-EIDA E.Y., EROS I., KATA M., J Incl Phenom, 34, 1999, p.39
3. SAVOLAINEN J., JARVINEN K., TAIPALE H., JARHO P., LOFTSSON T., JARVINEN T., Pharmaceutical Research, 15, 11, 1998, p.1696
4. MARTIN DEL VALLE E.M., Process Biochemistry, 39, 9, 2004, p.1033
5. SZEJTLI J., Chem. Rev., 98, 5, 1998, p.1743
6. th Int.Symp.on Cyclodextrins, Kluwer Academic Publ., Dordrecht, 1996, p.341
7. KREAZ R.M., ERÖS I., KATA M, Pharmazie, 53, 1998, p.498
8. MURA P., FAUCCI M.T., BETTINETTI G. P., Eur. J. Pharm. Sci, 13, 2001, p.187
9. ŞOICA C., GYÉRESI Á, AIGNER Z., KATA M., DEHELEAN C., Rev. Chim, 57, 4, 2006, p.392
10. *** European Pharmacopoeia, 5th Ed., 2004, Council of Europe, Strasbourg